Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 10.

Creutzig, U; Dworzak, M N; Zimmermann, M; Bourquin, J-P; Gruhn, B; Fleischhack, G; Graf, N; Klingebiel, T; Kremens, B; Lehrnbecher, T; von Neuhoff, C; Stackelberg, A V; Starý, J; Reinhardt, D (2015). Additional treatment with 2-Chloro-2-Deoxyadenosine during consolidation in children with high-risk acute myeloid leukemia does not improve survival. Leukemia, 29(11):2260-2263.

Creutzig, U; Dworzak, M; Zimmermann, M; Bourquin, J-P; Gruhn, B; Fleischhack, G; Graf, N; Klingebiel, T; Kremens, B; Lehrnbecher, T; von Neuhoff, C; von Stackelberg, A; Stray, J; Reinhardt, D (2015). Randomised Introduction of 2-CDA as Intensification during Consolidation for Children with High-risk AML--results from Study AML-BFM 2004. Klinische Pädiatrie, 227(3):116-122.

Creutzig, U; Zimmermann, M; Bourquin, J P; Dworzak, M N; Kremens, B; Lehrnbecher, T; von Neuhoff, C; Sander, A; von Stackelberg, A; Schmid, I; Starý, J; Steinbach, D; Vormoor, J; Reinhardt, D (2012). Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report. Leukemia, 26(4):654-661.

Creutzig, U; Zimmermann, M; Bourquin, J P; Dworzak, M N; Fleischhack, G; von Neuhoff, C; Sander, A; Schrauder, A; von Stackelberg, A; Ritter, J; Starý, J; Reinhardt, D (2011). CNS irradiation in pediatric acute myleoid leukemia: equal results by 12 or 18 Gy in studies AML-BFM98 and 2004. Pediatric Blood & Cancer, 57(6):986-992.

Creutzig, U; Zimmermann, M; Bourquin, J P; Dworzak, M N; von Neuhoff, C; Sander, A; Schrauder, A; Teigler-Schlegel, A; Stary, J; Corbacioglu, S; Reinhardt, D (2011). Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16). Blood, 118(20):5409-5415.

Wrigley, S N; Elbedweihy, K; Reinhardt, D; Bernstein, A; Ciravegna, F (2010). Evaluating semantic search tools using the SEALS platform. In: International Workshop on Evaluation of Semantic Technologies (IWEST 2010) Workshop, Shanghai, China, 8 November 2010 - 8 November 2010.

Creutzig, U; Zimmermann, M; Dworzak, M; Urban, C; Henze, G; Kremens, B; Lakomek, M; Bourquin, J P; Stary, J; Reinhardt, D (2010). Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses. British Journal of Haematology, 149(3):399-409.

Breuillin, F; Schramm, J; Hajirezaei, M; Ahkami, A; Favre, P; Druege, U; Hauser, B; Bucher, M; Kretzschmar, T; Bossolini, E; Kuhlemeier, C; Martinoia, E; Franken, P; Scholz, Uwe; Reinhardt, D (2010). Phosphate systemically inhibits development of arbuscular mycorrhiza in Petunia hybrida and represses genes involved in mycorrhizal functioning. The Plant Journal, 64(6):1002-1017.

von Neuhoff, C; Reinhardt, D; Sander, A; Zimmermann, M; Bradtke, J; Betts, D R; Zemanova, Z; Stary, J; Bourquin, J P; Haas, O A; Dworzak, M N; Creutzig, U (2010). Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98. Journal of Clinical Oncology, 28(16):2682-2689.

Malinge, S; Ragu, C; Della-Valle, V; Pisani, D; Constantinescu, S N; Perez, C; Villeval, J-l; Reinhardt, D; Landman-Parker, J; Michaux, L; Dastugue, N; Baruchel, A; Vainchenker, W; Bourquin, J-P; Penard-Lacronique, V; Bernard, O A (2008). Activating mutations in human acute megakaryoblastic leukemia. Blood, 112(10):4220-4226.

This list was generated on Fri Dec 15 12:15:47 2017 CET.